Syros Pharmaceuticals, Inc.
SYRS
$0.032
-$0.0067-17.31%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -48.07% | -45.16% | -34.68% | -31.03% | -54.10% |
| Total Receivables | -- | -- | -- | -- | -5.99% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -34.47% | -13.57% | -35.85% | -26.24% | 42.59% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -47.82% | -44.36% | -35.38% | -31.42% | -51.44% |
|
|
|||||
| Total Current Assets | -47.82% | -44.36% | -35.38% | -31.42% | -51.44% |
| Net Property, Plant & Equipment | -12.46% | -20.90% | -21.25% | -20.99% | -21.76% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -32.97% | -32.66% | -52.55% | -56.00% | -23.01% |
| Total Assets | -42.49% | -41.03% | -34.38% | -31.21% | -48.09% |
|
|
|||||
| Total Accounts Payable | 237.86% | 11.59% | 305.94% | 80.07% | -78.07% |
| Total Accrued Expenses | -24.79% | -15.99% | -13.59% | -10.13% | -1.03% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -33.93% | 15.03% | 274.16% | 334.14% | 89.03% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -91.45% |
| Total Other Current Liabilities | -- | -- | -- | -- | -91.45% |
| Total Current Liabilities | -0.01% | -13.58% | 58.39% | 19.18% | -26.10% |
|
|
|||||
| Total Current Liabilities | -0.01% | -13.58% | 58.39% | 19.18% | -26.10% |
| Long-Term Debt | 4.25% | 0.01% | -24.05% | -14.99% | -2.73% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -13.49% | -12.64% | -11.86% | -11.14% | -10.49% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -58.92% | 62.39% | 122.80% | 152.32% | -55.55% |
| Total Liabilities | -13.79% | 4.95% | 21.41% | 29.77% | -28.33% |
|
|
|||||
| Common Stock & APIC | 7.25% | 7.52% | 7.71% | 7.82% | 1.74% |
| Retained Earnings | -14.86% | -21.28% | -24.83% | -29.48% | -18.97% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -130.64% | -108.67% | -85.90% | -86.96% | -71.90% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -130.64% | -108.67% | -85.90% | -86.96% | -71.90% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -130.64% | -108.67% | -85.90% | -86.96% | -71.90% |
|
|
|||||